Lumos Diagnostics Holdings Ltd Capital Reinvestment Ratio

Latest as of December 2025: 0.24x

Lumos Diagnostics Holdings Ltd capital reinvestment ratio. Lumos Diagnostics Holdings Ltd (LDX) has a Capital Reinvestment Ratio of 0.24x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$778.03K) in capital expenditures (AU$189.41K). Check LDX capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.24x
Capex / Operating Cash Flow

Operating Cash Flow

AU$778.03K
AUD

Capital Expenditures

AU$189.41K
AUD

Data as of

Dec 2025
Most recent filing

Capital Reinvestment Ratio of Lumos Diagnostics Holdings Ltd (2023–2023)

Capital reinvestment ratio of Lumos Diagnostics Holdings Ltd from 2023 to 2023. This chart tracks Lumos Diagnostics Holdings Ltd's Capital Reinvestment Ratio across 1 annual periods. Also explore LDX shareholders equity momentum to track the company's year-over-year net asset growth rate.

Lumos Diagnostics Holdings Ltd Capital Reinvestment Ratio by Year (2023–2023)

Lumos Diagnostics Holdings Ltd capital reinvestment ratio by year from 2023 to 2023. For the full cash flow conversion analysis, see Lumos Diagnostics Holdings Ltd (LDX) cash flow conversion.

Year Reinvestment Ratio Operating CF (AUD) Capital Expenditures YoY Change
2023 0.10x AU$946.00K AU$98.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow